116 related articles for article (PubMed ID: 28609836)
1. Beam Me In: Thyroid Hormone Analog Targets Alternative Transporter in Mouse Model of X-Linked Adrenoleukodystrophy.
Milanesi A; Brent GA
Endocrinology; 2017 Apr; 158(5):1116-1119. PubMed ID: 28609836
[No Abstract] [Full Text] [Related]
2. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2).
Fourcade S; Savary S; Gondcaille C; Berger J; Netik A; Cadepond F; El Etr M; Molzer B; Bugaut M
Mol Pharmacol; 2003 Jun; 63(6):1296-303. PubMed ID: 12761339
[TBL] [Abstract][Full Text] [Related]
4. Autonomic dysfunction in a patient with X-linked adrenoleukodystrophy.
Zhang Y; Guo D; Tang Y
Int J Neurosci; 2018 Aug; 128(8):783-784. PubMed ID: 29284317
[TBL] [Abstract][Full Text] [Related]
5. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.
Engelen M; Barbier M; Dijkstra IM; Schür R; de Bie RM; Verhamme C; Dijkgraaf MG; Aubourg PA; Wanders RJ; van Geel BM; de Visser M; Poll-The BT; Kemp S
Brain; 2014 Mar; 137(Pt 3):693-706. PubMed ID: 24480483
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress regulates the ubiquitin-proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy.
Launay N; Ruiz M; Fourcade S; Schlüter A; Guilera C; Ferrer I; Knecht E; Pujol A
Brain; 2013 Mar; 136(Pt 3):891-904. PubMed ID: 23436506
[TBL] [Abstract][Full Text] [Related]
7. Exon organisation of the mouse gene encoding the Adrenoleukodystrophy related protein (ALDRP).
Broccardo C; Troffer-Charlier N; Savary S; Mandel JL; Chimini G
Eur J Hum Genet; 1998; 6(6):638-41. PubMed ID: 9887385
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the adrenoleukodystrophy-related gene (ABCD2): focus on oxysterols and LXR antagonists.
Trompier D; Gondcaille C; Lizard G; Savary S
Biochem Biophys Res Commun; 2014 Apr; 446(3):651-5. PubMed ID: 24480443
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy.
Fourcade S; López-Erauskin J; Ruiz M; Ferrer I; Pujol A
Biochimie; 2014 Mar; 98():143-9. PubMed ID: 24076127
[TBL] [Abstract][Full Text] [Related]
10. Full length cDNA cloning, promoter sequence, and genomic organization of the human adrenoleukodystrophy related (ALDR) gene functionally redundant to the gene responsible for X-linked adrenoleukodystrophy.
Holzinger A; Mayerhofer P; Berger J; Lichtner P; Kammerer S; Roscher AA
Biochem Biophys Res Commun; 1999 May; 258(2):436-42. PubMed ID: 10329405
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 and neurotrophin-3 gene therapy prevents motor decline in an X-linked adrenoleukodystrophy mouse model.
Mastroeni R; Bensadoun JC; Charvin D; Aebischer P; Pujol A; Raoul C
Ann Neurol; 2009 Jul; 66(1):117-22. PubMed ID: 19670442
[TBL] [Abstract][Full Text] [Related]
12. Mutational analyses on X-linked adrenoleukodystrophy reveal a novel cryptic splicing and three missense mutations in the ABCD1 gene.
Hung KL; Wang JS; Keng WT; Chen HJ; Liang JS; Ngu LH; Lu JF
Pediatr Neurol; 2013 Sep; 49(3):185-90. PubMed ID: 23835273
[TBL] [Abstract][Full Text] [Related]
13. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
14. Three novel variants in X-linked adrenoleukodystrophy.
Shukla P; Gupta N; Kabra M; Ghosh M; Sharma R; Gupta AK; Gulati S; Kalra V
J Child Neurol; 2009 Jul; 24(7):857-60. PubMed ID: 19406751
[TBL] [Abstract][Full Text] [Related]
15. Linking mutated primary structure of adrenoleukodystrophy protein with X-linked adrenoleukodystrophy.
Yan S; Wu G
Comput Methods Biomech Biomed Engin; 2010 Jun; 13(3):403-11. PubMed ID: 20077240
[TBL] [Abstract][Full Text] [Related]
16. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
[TBL] [Abstract][Full Text] [Related]
17. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
[TBL] [Abstract][Full Text] [Related]
18. Structure and location of the murine adrenoleukodystrophy gene.
Kennedy MA; Rowland SA; Miller AL; Morris CM; Neville LA; Dodd A; Fifield WJ; Love DR
Genomics; 1996 Mar; 32(3):395-400. PubMed ID: 8838803
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
Fourcade S; Ruiz M; Guilera C; Hahnen E; Brichta L; Naudi A; Portero-Otín M; Dacremont G; Cartier N; Wanders R; Kemp S; Mandel JL; Wirth B; Pamplona R; Aubourg P; Pujol A
Hum Mol Genet; 2010 May; 19(10):2005-14. PubMed ID: 20179078
[TBL] [Abstract][Full Text] [Related]
20. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
Kemp S; Wanders RJ
Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
